IndraLab

Statements


EGFR-vIII inhibits USP11. 2 / 2
| 2

reach
"In addition, EGFR-vIII enhanced silencing of the USP11 promoter through the PI3K and AKT-HDAC 1/2 axis."

reach
"In addition, EGFR-vIII enhanced silencing of the USP11 promoter through the PI3K/AKT-HDAC1/2 axis.A dynamic balance between histone acetylation and deacetylation is maintained to regulate gene expression appropriately; a disturbance in this balance in cancer though altered gene expression can accelerate cell cycle progression [47]."